Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,763.20
(
-0.14%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.35
(
-2.09%
)
Bitcoin
70,325.46
(
-1.29%
)
News Focus
News Focus
Post# of 257261
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 24
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: DewDiligence post# 111957

Wednesday, 01/05/2011 9:06:02 PM

Wednesday, January 05, 2011 9:06:02 PM

Post# of 257261
Rituxan has several NHL indications in the label.

Front-line agressive
Relasped Refractory indolent
Frontline Indolent
Maintenance
Etc....


For a biosimilar, will it also need ph 3 trials in each of the NHL subindications to get approval in those area?

This is specific to Rituxan, but i have that general question about biosimilars?
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now